Publicacions (142) Publicacions en què ha participat algun/a investigador/a

2024

  1. Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New Perspective

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

  2. Changes in AmotL2 Expression in Cells of the Human Enteral Nervous System in Oxaliplatin-Induced Enteric Neuropathy

    Biomedicines, Vol. 12, Núm. 9

  3. Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma

    International Journal of Molecular Sciences, Vol. 25, Núm. 6, pp. 3115

  4. Cilastatin, a new therapeutic promise for acute kidney injury

    Kidney International

  5. Creación de una comunidad de aprendizaje para el desarrollo de una estructura de mentorizaje vertical y generación de contenidos digitales para la formación en competencias de investigación y mejora de la empleabilidad

    III Jornada «Aprendizaje Eficaz con TIC en la UCM» (Ediciones Complutense), pp. 69-82

  6. Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

    BMC Neuroscience, Vol. 25, Núm. 1

  7. Induction of sepsis in a rat model by the cecal ligation and puncture technique. Application for the study of experimental acute renal failure

    Methods in Cell Biology (Academic Press Inc.)

  8. Trabajo en equipo: ¿todavía un reto para el estudiante universitario? Unavisión práctica desde los seminarios de Etología

    I Congreso en Innovación Docente de las Universidades Madriñeñas: MadrID

  9. Tubular biomarkers and histology in lupus nephritis

    International Journal of Rheumatic Diseases, Vol. 27, Núm. 6

  10. Tubular biomarkers in proteinuric kidney disease: histology correlation and kidney prognosis of tubular biomarkers

    Clinical Kidney Journal, Vol. 17, Núm. 5

  11. Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages

    Life Science Alliance, Vol. 7, Núm. 6

  12. Untargeted metabolomics analysis of serum and urine unveils the protective effect of cilastatin on altered metabolic pathways during cisplatin-induced acute kidney injury

    Biochemical Pharmacology, Vol. 227

2023

  1. Novel Experimental Mouse Model to Study Malaria-Associated Acute Kidney Injury

    Pathogens, Vol. 12, Núm. 4

2022

  1. FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats

    Cells, Vol. 11, Núm. 9, pp. 1585

  2. Inclusión con sentido

    Anuncios: Semanario de publicidad y marketing, Núm. 1668, pp. 33-33

  3. La Fisiología: base de las Ciencias Médicas y Biológicas

    Encuentros multidisciplinares, Vol. 24, Núm. 71

  4. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  5. Role of Glucocorticoid Signaling and HDAC4 Activation in Diaphragm and Gastrocnemius Proteolytic Activity in Septic Rats

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  6. Upregulation of TLR4/MyD88 pathway in alcohol-induced Wernicke’s encephalopathy: Findings in preclinical models and in a postmortem human case

    Frontiers in Pharmacology, Vol. 13

  7. “Shikonin inhibits microglia activation and reduces CFA-induced mechanical hyperalgesia in an animal model of pain”

    Biomedicine and Pharmacotherapy, Vol. 150